FDA requests removal of suicide warnings from weight-loss drug labels
FDA Removes Suicide Risk Warning from Weight Loss Drugs: What’s Next for GLP-1s? The Food and Drug Administration’s recent decision to lift warnings about potential suicidal thoughts linked to popular GLP-1 weight loss drugs – Wegovy, Zepbound, and Saxenda – marks a significant turning point. This isn’t just about removing a label; it’s a signal … Read more